Opportunity ID: 340865
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-22-MRP-IA |
Funding Opportunity Title: | DoD Melanoma, Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 13 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jun 01, 2022 |
Last Updated Date: | Oct 03, 2022 |
Original Closing Date for Applications: | Oct 05, 2022 |
Current Closing Date for Applications: | Oct 05, 2022 |
Archive Date: | Nov 04, 2022 |
Estimated Total Program Funding: | $10,400,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public. The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis. The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
USAMRAA and CDMRP understand that the effects of Hurricane Ian may be preventing some from submitting their applications. Therefore a 5 day grace period (until 10 October 2022 at 11:59pm ET) is being added only for those affected by the storm (i.e., applicants whose institution is within a FEMA declared disaster area). Please also note, that if you submit an application during the grace period, then you must also submit an appeal to the eBRAP help desk to explain how you were affected by the storm. If you do not submit an appeal with your grace period application, then your application will not be accepted. If you submit an application during the grace period and were not affected by Hurricane Ian, then your application will not be accepted. | Oct 03, 2022 | |
Jun 01, 2022 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-22-MRP-IA |
Funding Opportunity Title: | DoD Melanoma, Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 13 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jun 01, 2022 |
Last Updated Date: | Oct 03, 2022 |
Original Closing Date for Applications: | Oct 05, 2022 |
Current Closing Date for Applications: | Oct 05, 2022 |
Archive Date: | Nov 04, 2022 |
Estimated Total Program Funding: | $10,400,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public. The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis. The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-22-MRP-IA |
Funding Opportunity Title: | DoD Melanoma, Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 13 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jun 01, 2022 |
Last Updated Date: | Jun 01, 2022 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Oct 05, 2022 |
Archive Date: | Nov 04, 2022 |
Estimated Total Program Funding: | $10,400,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public. The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis. The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Related Documents
Packages
Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00274747 | Jun 01, 2022 | Oct 05, 2022 | View |